Archean Chemical Industries Ltd

Archean Chemical Industries Ltd announced the release of 5,200 shares from pledge by promoter Chemikas Speciality LLP on July 22, 2026. This release represents 0.004% of the total capital and 0.014% of the promoter's holding. The pledge was released after the repayment of a loan availed from JM Financial Products Limited. Following this release, the total encumbered shares held by Chemikas Speciality LLP are now 2,82,65,965, representing 22.90% of the total capital.

Archean Chemical Industries Ltd announced the outcome of its Board Meeting held on July 30, 2026. The board approved the Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026. These results were reviewed by the Audit Committee and approved by the Board. A Limited Review Report from the Statutory Auditors was also provided. The financial results will be published in newspapers as per SEBI regulations. The company is engaged in the manufacturing of Marine Chemicals.

Archean Chemical Industries reported a Q1 FY27 (quarter ended June 30, 2026) in which the topline grew but profitability shrank — the classic signature of a pricing squeeze rather than a demand problem. On a consolidated basis, which is the primary lens given the subsidiary drag, revenue from operations rose ~11.9% YoY to ₹327.2 Cr (from ₹292.4 Cr), yet net profit fell ~24.4% YoY to ₹30.35 Cr (from ₹40.14 Cr). Net margin compressed from 13.4% a year ago to ~9.3%, and operating margin (EBITDA) narrowed to roughly 20.6% from ~26.7% — the entire gap sits on cost of materials and other expenses outrunning realisations, consistent with the older, lower-priced bromine contracts management had flagged. EPS more than halved sequentially-adjusted terms is misleading, but YoY it dropped from ₹3.25 to ₹2.48. The sequential picture looks dramatic — consolidated PAT up from ₹12.23 Cr in Q4 FY26 — but that is off a depressed base: Q4 carried an abnormally low PBT of ₹15.86 Cr, so the QoQ 'recovery' is base-effect, not a genuine acceleration, and should not headline. The standalone entity actually earned more (₹40.53 Cr PAT on ₹315.9 Cr revenue) than the consolidated group, because the pre-operational subsidiaries — Neun Infra, Idealis Chemicals/Mudchemie and Sicsem — collectively booked a net loss of ~₹9.98 Cr before consolidation adjustments; this is the growth-investment phase showing up as a drag, not an operating deterioration in the core marine-chemicals business. The result confirms rather than contradicts the cautious tone from the Q3 FY26 concall, where management guided to bromine pricing being pressured by legacy contracts near-term while targeting a return to steady-state (>18,000 tons) bromine output over FY27 and a ramp of derivatives to 50–60% utilisation; the SOP project's meaningful contribution was already pushed to H2 FY27. This print — revenue holding up on volume while margins bleed on price — is exactly that story playing out. No formal quantitative earnings guidance is on record, and with the print landing today and the concall only on Aug 3, no published street consensus for the quarter was available to benchmark against. Concurrent corporate actions during the quarter — the ₹170 Cr rights-issue subscription into wholly-owned Acume Chemicals (allotted June 17), Sicsem's Fiscal Support Agreement with the India Semiconductor Mission (up to 75% capex support), and a small promoter pledge release — point to continued capital deployment into the subsidiary pipeline that is currently loss-making.

Archean Chemical Industries Ltd has disclosed the release of a pledge on 5,200 shares held by Chemikas Speciality LLP, a promoter entity. The release, dated July 22, 2026, signifies the repayment of a loan availed by the promoter from JM Financial Products Limited. This action reduces the encumbered shares by 0.004% of the company's capital and 0.014% of the promoter's holding. The total number of shares still under pledge post-release is 2,82,65,965.

Archean Chemical Industries Ltd has submitted its Reconciliation of Share Capital Audit Report for the quarter ended June 30, 2026, as per SEBI regulations. The report confirms that the company's issued capital of 12,34,58,394 shares (face value ₹2 each) totaling ₹24,69,16,788 is fully listed and matches the total number of shares. The audit, conducted by HVS & Associates, found no discrepancies between issued, listed, and total shares. All shares are held in dematerialized form, with 92.91% in NSDL and 7.09% in CDSL, and no shares are held in physical form. The Register of Members has been updated, and there were no pending demat requests beyond 21 days during the quarter.

Archean Chemical Industries Ltd has announced that its Board of Directors will convene on July 30, 2026, in Chennai. The primary agenda item is to consider and approve the un-audited standalone and consolidated financial results for the first quarter ended June 30, 2026. Following the meeting, the company will disseminate the results and publish them as per SEBI regulations. Additionally, the trading window for designated persons and their relatives will remain closed until August 1, 2026, in line with insider trading regulations.

Archean Chemical Industries Ltd has responded to stock exchange queries regarding unusual trading volume. The company stated it is compliant with SEBI regulations and has disclosed all material information. Archean Chemical clarified that there is no undisclosed price-sensitive information or impending corporate action that would explain the trading volume surge. The movement is attributed to market-driven factors. The company assures continued compliance with disclosure requirements.

Archean Chemical Industries Ltd announced a significant development concerning its investment in Offgrid Energy Labs Inc. Offgrid has inaugurated its first Zinc Bromide based battery (ZincGel®) pilot manufacturing facility, a 10 MWh demonstration line, in Hook, Hampshire, United Kingdom. This marks the transition of Offgrid's proprietary ZincGel® technology from laboratory innovation to commercial pilot-scale production. The facility aligns with Archean Chemical's strategic objective of investing in Offgrid and establishes a foundation for future large-scale battery manufacturing, including a planned gigafactory in India. There is no additional financial commitment from Archean Chemical arising from this development. The ZincGel® technology is designed for long-duration stationary energy storage applications.

Archean Chemical Industries Ltd has received a revised disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, concerning Chemikas Speciality LLP. The disclosure details the creation and release of pledges on promoter shares. Specifically, 10,00,000 shares were pledged with Aditya Birla Capital for loans, and 79,00,000 shares were pledged with CTL Trusteeship Limited/JM Financial Credit Solutions Limited for loans. Subsequently, 49,30,000 shares were released from pledge with Bajaj Finance Limited, and 9,99,990 shares were released by Aditya Birla Capital, following loan repayments.

Archean Chemical Industries Ltd has filed a revised disclosure regarding promoter share encumbrance. Chemikas Speciality LLP, a promoter, created a pledge of 8,50,000 shares (0.69% of capital) on June 30, 2026, as collateral for loan repayment to CTL Trusteeship Limited/JM Financial Credit Solutions Limited. Subsequently, on July 3, 2026, 22,00,000 shares (1.78% of capital) were released from a pledge to HDFC Bank Limited after loan repayment. The filing details the changes in promoter holding and encumbered shares.